Roche
Roche Gets 510(k) Clearance, CLIA Waiver for Liat Triplex Point-of-Care STI Test
The firm will begin offering the test in the US followed by commercialization under CE marking.
Foundation Medicine Assay Nabs FDA Approval as CDx for Ojemda in Pediatric Patients
The FoundationOne test can be used to identify patients with relapsed or refractory BRAF-altered pediatric low-grade glioma who may be eligible for therapeutic options.
Foresight Diagnostics, Stanford, Others File Motions to Dismiss Roche Suit
Foresight said Roche failed to bring its trade-secret causes of action within the three-year statute of limitations.
Roche Receives CE Mark for Updated High-Throughput Cobas Platform
The new Cobas 6800/8800 systems 2.0 enhances throughput and run flexibility and enables sample prioritization.
HER2 Biomarker Evolving as Enhertu Shows Activity in Breast Cancers With Ultralow Expression
Premium
The new HER2-low category is exposing the limitations of IHC testing, challenging pathologists, and has oncologists revisiting patients' old test results.
Nov 12, 2024
Tempus to Offer Cancer Tests Through Flatiron's EMR
Oct 21, 2024
WHO Approves Roche Mpox Assay
Oct 1, 2024
Aug 5, 2024
Jul 24, 2024